{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:50:08Z","timestamp":1784191808757,"version":"3.55.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/inf.0b013e318242590e","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T11:35:39Z","timestamp":1323948939000},"page":"353-359","source":"Crossref","is-referenced-by-count":16,"title":["A Meta-analysis of Antipseudomonal Penicillins and Cephalosporins in Pediatric Patients With Fever and Neutropenia"],"prefix":"10.1097","volume":"31","author":[{"given":"Arif","family":"Manji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Lee","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.","volume":"284","author":"Schimpff","year":"1971","journal-title":"N Engl J Med"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","article-title":"Management of fever in patients with cancer and treatment-induced neutropenia.","volume":"328","author":"Pizzo","year":"1993","journal-title":"N Engl J Med"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1440-1754.2005.00729.x","article-title":"Prospective audit of treatment of paediatric febrile neutropenia in Australasia.","volume":"41","author":"Chamberlain","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/pbc.20810","article-title":"Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.","volume":"48","author":"Boragina","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/adc.2006.102699","article-title":"United Kingdom Childrens Cancer Study Group. Variation in policies for the management of febrile neutropenia in United Kingdom Childrens Cancer Study Group centres.","volume":"92","author":"Phillips","year":"2007","journal-title":"Arch Dis Child"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijantimicag.2005.01.020","article-title":"Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.","volume":"25","author":"Greenberg","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data.","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews.","volume":"144","author":"Hayden","year":"2006","journal-title":"Ann Intern Med"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08880010500506370","article-title":"Monotherapy with piperacillintazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.","volume":"23","author":"Corapcioglu","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S1413-86702003000200003","article-title":"Evaluation of ticarcillinclavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.","volume":"7","author":"Petrilli","year":"2003","journal-title":"Braz J Infect Dis"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/pbc.22100","article-title":"Piperacillintazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study.","volume":"53","author":"Uygun","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1442-200X.2009.02952.x","article-title":"Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.","volume":"52","author":"Vural","year":"2010","journal-title":"Pediatr Int"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/08880010490277321","article-title":"Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.","volume":"21","author":"Aksoylar","year":"2004","journal-title":"Pediatr Hematol Oncol"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/27.5.669","article-title":"Clinical evaluation of ticarcillin, with clavulanic acid, and gentamicin in the treatment of febrile episodes in neutropenic children.","volume":"27","author":"Bolton-Maggs","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R19-7-20210202","first-page":"105","article-title":"Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors.","volume":"43","author":"Duzova","year":"2001","journal-title":"Turk J Pediatr"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0011-393X(95)85117-8","article-title":"Comparison of cefoperazone-sulbactam versus piperacillin plus amikacin as empiric therapy in pediatric febrile neutropenic cancer patients.","volume":"56","author":"El Haddad","year":"1995","journal-title":"Curr Ther Res Clin Exp"},{"key":"R21-7-20210202","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s005200000225","article-title":"Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.","volume":"9","author":"Fleischhack","year":"2001","journal-title":"Support Care Cancer"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/47.6.841","article-title":"Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.","volume":"47","author":"Fleischhack","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R23-7-20210202","first-page":"13","article-title":"Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.","volume":"6","author":"Gonzalez","year":"1987","journal-title":"P R Health Sci J"},{"key":"R24-7-20210202","first-page":"26","article-title":"Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.","volume":"49","author":"Hamidah","year":"2008","journal-title":"Singapore Med J"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1651-2227.2005.tb03068.x","article-title":"Once-daily netilmicin for neutropenic pyrexia in paediatric oncology.","volume":"94","author":"Hemsworth","year":"2005","journal-title":"Acta Paediatr"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/28.1.117","article-title":"Aztreonam therapy in children with febrile neutropenia: a randomized trial of aztreonam plus flucloxacillin versus piperacillin plus gentamicin.","volume":"28","author":"Heney","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R27-7-20210202","first-page":"331","article-title":"Empirical antimicrobial therapy in pediatric patients with neutropenia and fever. Risk factors for treatment failure.","volume":"29","author":"Miranda-Novales","year":"1998","journal-title":"Arch Med Res"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1056\/NEJM198810203191604","article-title":"Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.","volume":"319","author":"Shenep","year":"1988","journal-title":"N Engl J Med"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0163-4453(90)91019-A","article-title":"Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children.","volume":"20","author":"Smith","year":"1990","journal-title":"J Infect"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/1120009X.1991.11739100","article-title":"The efficacy of mezlocillin-amikacin combination in febrile neutropenic children with oncologic disease.","volume":"3","author":"Zulfikar","year":"1991","journal-title":"J Chemother"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08880010802016847","article-title":"Piperacillintazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.","volume":"25","author":"Yildirim","year":"2008","journal-title":"Pediatr Hematol Oncol"},{"key":"R33-7-20210202","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1440-1754.2006.00977.x","article-title":"Cefepime monotherapy for treatment of febrile neutropenia in children.","volume":"42","author":"Ariffin","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"R34-7-20210202","first-page":"531","article-title":"Oral vs. intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy.","volume":"85","author":"Cagol","year":"2009","journal-title":"J Pediatr (Rio J)"},{"key":"R35-7-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006454-200203000-00009","article-title":"Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.","volume":"21","author":"Chuang","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R36-7-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08880010590896297","article-title":"Cefepime versus ceftazidime amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.","volume":"22","author":"Corapcioglu","year":"2005","journal-title":"Pediatr Hematol Oncol"},{"key":"R37-7-20210202","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00006454-198803000-00006","article-title":"Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.","volume":"7","author":"Granowetter","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"R38-7-20210202","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01728894","article-title":"Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children.","volume":"21","author":"Jacobs","year":"1993","journal-title":"Infection"},{"key":"R39-7-20210202","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/mpo.1107","article-title":"Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.","volume":"36","author":"Kebudi","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R40-7-20210202","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/pbc.10442","article-title":"Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.","volume":"42","author":"Kutluk","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"R41-7-20210202","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<126::AID-CNCR18>3.0.CO;2-1","article-title":"Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.","volume":"86","author":"Mullen","year":"1999","journal-title":"Cancer"},{"key":"R42-7-20210202","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00006454-200103000-00036","article-title":"Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.","volume":"20","author":"Mustafa","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R43-7-20210202","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/08880010500506867","article-title":"Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.","volume":"23","author":"Oguz","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"key":"R44-7-20210202","first-page":"141","article-title":"Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.","volume":"42","author":"Pereira","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"R45-7-20210202","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/pbc.21692","article-title":"A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders.","volume":"51","author":"Sato","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R46-7-20210202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1440-1754.2001.00585.x","article-title":"Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer.","volume":"37","author":"Ariffin","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"R47-7-20210202","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00006454-199704000-00003","article-title":"Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children.","volume":"16","author":"Charnas","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R48-7-20210202","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-911X(200004)34:4<306::AID-MPO24>3.0.CO;2-2","article-title":"Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.","volume":"34","author":"Chastagner","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"R49-7-20210202","first-page":"615","article-title":"Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.","volume":"48","author":"Hamidah","year":"2007","journal-title":"Singapore Med J"},{"key":"R50-7-20210202","first-page":"254","article-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.","volume":"36","author":"Hung","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"R51-7-20210202","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/08880010701703636","article-title":"Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides.","volume":"24","author":"Laoprasopwattana","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"R52-7-20210202","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0924-8579(01)00420-4","article-title":"Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.","volume":"18","author":"Maltezou","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"R53-7-20210202","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/clinids\/13.3.397","article-title":"Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.","volume":"13","author":"Viscoli","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R55-7-20210202","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(07)70109-3","article-title":"Efficacy and safety of cefepime: a systematic review and meta-analysis.","volume":"7","author":"Yahav","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R56-7-20210202","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/655131","article-title":"Meta-analysis of a possible signal of increased mortality associated with cefepime use.","volume":"51","author":"Kim","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R57-7-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1473-3099(02)00241-4","article-title":"Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.","volume":"2","author":"Furno","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"R58-7-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.","volume":"326","author":"Paul","year":"2003","journal-title":"BMJ"},{"key":"R59-7-20210202","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201204000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:01:13Z","timestamp":1618034473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201204000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318242590e","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}